Galena Biopharma
  • About Us
    • Leadership
    • Career Opportunities
  • Products
    • Abstral®
  • Clinical Development
    • Pipeline
    • Clinical Trials
    • NeuVax™ (nelipepimut-S)
    • FBP (E39)
    • Technology
  • Business Development
  • Investors
    • Stock Information
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Email Alerts
    • Corporate Governance
    • Analyst Coverage
  • News
  • Resources
Discovery. Delivery. Development. Technology

Galena Biopharma is committed to being a partner of choice for academia, small companies, and large multinationals. Galena’s experienced management team has an excellent track record in clinical development, commercial operations, as well as successful partnership execution.

We are actively seeking commercialization partners for our current clinical programs in selected regions of the world.

We also welcome ideas and proposals for strategic alliances, including in-licensing opportunities for commercial and late stage oncology products.

Please call Dr. Mark Schwartz at 1- 855-855 GALE, ext. 115 or email him at: schwartz@galenabiopharma.com

Thank you very much for your consideration.

Email | Print
  • Home
  • Legal
  • LinkedIn
  • Galena Biopharma. All rights reserved.
info@galenabiopharma.com
1-855-855-GALE
310 N. State Street, Suite 208 | Lake Oswego, OR 97034